Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CitraNatal + docosahexaenoic acid is a prescription-strength prenatal supplement system manufactured by Mission Pharmacal. It is designed to provide comprehensive nutritional support for women during preconception, pregnancy, and the postpartum period. The product typically consists of a multivitamin/mineral tablet or capsule co-packaged with a softgel containing docosahexaenoic acid (DHA). The multivitamin component features essential nutrients including high-dose folic acid (often as Quatrefolic) to reduce the risk of neural tube defects, iron (in forms like carbonyl iron or ferrous gluconate) to support increased maternal blood volume and prevent anemia, and various other vitamins and minerals such as Vitamin D3, Vitamin C, and Calcium. The DHA component is an omega-3 fatty acid critical for the healthy development of the fetal brain, nervous system, and eyes. As a prescription product, it provides higher levels of certain nutrients, particularly folic acid, than are typically found in over-the-counter prenatal vitamins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CitraNatal + docosahexaenoic acid.